SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001818382-24-000047
Filing Date
2024-04-29
Accepted
2024-04-29 07:12:39
Documents
6
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A huma-2024def14a.htm DEF 14A 527038
2 ceosignature.jpg GRAPHIC 51912
3 logo.jpg GRAPHIC 21724
4 proxycard_pagex1.jpg GRAPHIC 75804
5 proxycard_pagex2.jpg GRAPHIC 72865
6 skillstable.jpg GRAPHIC 129038
  Complete submission text file 0001818382-24-000047.txt   1010656
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39532 | Film No.: 24886572
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)